Hadizadeh, Hasti
Flores, José M.
Mayerson, Talia
Worhunsky, Patrick D.
Potenza, Marc N.
Angarita, Gustavo A.
Funding for this research was provided by:
National Institute on Drug Abuse (R21 DA040914, R21 DA043055, R01 DA052454, R01 DA039136, K01 DA042998)
Fredrick C. and Herta G. Redlich Research Fund
Daniel X and Mary Freedman Foundation
Neuroscience Research Training Program
Article History
Accepted: 16 August 2022
First Online: 19 September 2022
Declarations
:
: The authors report that they have no financial conflicts of interest with respect to the content of this manuscript. Dr. Potenza has the following relationships to disclose: Dr. Potenza has consulted for and advised Game Day Data, Opiant Pharmaceuticals, Idorsia, BariaTek, the Addiction Policy Forum, and AXA; has been involved in a patent application with Yale University and Novartis; has received research support from the Mohegan Sun Casino and the Connecticut Council on Problem Gambling; has participated in surveys, mailings, or telephone consultations related to addictive disorders or other health topics; has consulted for or advised law offices and gambling entities on issues related to addictive disorders and behaviors; has provided clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews; has edited journals and journal sections; has given academic lectures in grand rounds, CME events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).